(Q36250121)

English

Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda (English)

1 reference

Europe PubMed Central

13 August 2017

0 references

Plasmodium falciparum

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michael T. White

object named as

Michael T White

4

0 references

Bernard N Kanoi

object named as

Bernard N Kanoi

1

0 references

Nirianne Marie Q Palacpac

5

object named as

Nirianne M Q Palacpac

1 reference

Europe PubMed Central

13 August 2017

Betty Balikagala

7

object named as

Betty Balikagala

1 reference

Europe PubMed Central

13 August 2017

Toshihiro Horii

object named as

Toshihiro Horii

10

0 references

Takafumi Tsuboi

object named as

Takafumi Tsuboi

11

0 references

author name string

Eizo Takashima

2

1 reference

Europe PubMed Central

13 August 2017

Masayuki Morita

3

1 reference

Europe PubMed Central

13 August 2017

Edward H Ntege

6

1 reference

Europe PubMed Central

13 August 2017

Adoke Yeka

8

1 reference

Europe PubMed Central

13 August 2017

Thomas G Egwang

9

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

12 January 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

35

1 reference

Europe PubMed Central

13 August 2017

6

1 reference

Europe PubMed Central

13 August 2017

873-881

1 reference

Europe PubMed Central

13 August 2017

Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Artemisinin Resistance in Plasmodium falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Immunity to non-cerebral severe malaria is acquired after one or two infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Patterns in age-specific malaria incidence in a population exposed to low levels of malaria transmission intensity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Mechanisms of defense against P. falciparum asexual blood stages in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

STUDIES IN THE ACQUISITION OF IMMUNITY OF PLASMODIUM FALCIPARUM INFECTIONS IN AFRICA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Clinical immunity to malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Progress and prospects for blood-stage malaria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

A field trial to assess a blood-stage malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

New antigens for a multicomponent blood-stage malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Profiling humoral immune responses to P. falciparum infection with protein microarrays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Novel approaches to identify protective malaria vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

High-throughput generation of P. falciparum functional molecules by recombinational cloning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Practical cell-free protein synthesis system using purified wheat embryos

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Simple screening method for autoantigen proteins using the N-terminal biotinylated protein library produced by wheat cell-free synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Continuing intense malaria transmission in northern Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Variation in malaria transmission intensity in seven sites throughout Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Acquired immunity to malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Systematic genetic analysis of the Plasmodium falciparum MSP7-like family reveals differences in protein expression, location, and importance in asexual growth of the blood-stage parasite

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Plasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Identification of GAPDH on the surface of Plasmodium sporozoites as a new candidate for targeting malaria liver invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Surface export of GAPDH/SDH, a glycolytic enzyme, is essential for Streptococcus pyogenes virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Vaccine candidates for malaria: what's new?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.01.001

7 January 2021

Identifiers

10.1016/J.VACCINE.2017.01.001

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36250121&oldid=1982136427"